文献速递肝病消化内镜

Baveno VI标准联合脾硬度测量可排除病毒抑制下HBV相关肝硬化患者的高风险静脉曲张

Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
PubMed 文献 · J Hepatol · 2020-10-08

该研究前瞻性纳入2019年4月至12月南方医院肝病中心341例持续病毒学抑制的HBV相关肝硬化患者,验证Baveno VI标准联合脾硬度测量(cut-off 46 kPa)排除高风险静脉曲张的性能。联合模型使61.6%(210/341)患者符合条件,漏诊高风险静脉曲张4.3%(3/70),灵敏度95.71%、特异度76.38%、阴性预测值98.57%、阴性似然比0.06。

要点

  • Baveno VI标准使37.0%(126/341)患者免于胃镜检查,未漏诊高风险静脉曲张(0/70)。
  • 脾硬度≤46.0 kPa可安全排除高风险静脉曲张,漏诊率4.3%。
  • 联合模型使61.6%(210/341)患者免于胃镜检查,漏诊高风险静脉曲张4.3%(3/70)。

核心结论

  • 在持续病毒学抑制的HBV相关肝硬化患者中,Baveno VI标准联合脾硬度测量(cut-off 46 kPa)可安全排除高风险静脉曲张,超过半数胃镜检查得以免除。

研究设计与样本

  • 前瞻性验证研究,2019年4月至12月于中国南方医院肝病中心纳入341例持续病毒学抑制的HBV相关肝硬化患者,入组时行肝脾瞬时弹性成像及食管胃十二指肠镜检查。

主要发现

  • 高风险静脉曲张患病率为20.5%(70/341)。
  • Baveno VI标准使37.0%(126/341)食管胃十二指肠镜检查得以免除,未漏诊高风险静脉曲张(0/70)。
  • 扩展Baveno VI标准将8例高风险静脉曲张(8/70,11.4%)误分类于208/341(61.0%)患者中。
  • 脾硬度cut-off≤46.0 kPa排除高风险静脉曲张的漏诊率为4.3%。
  • 联合模型(Baveno VI标准且脾硬度≤46 kPa)覆盖61.6%(210/341)患者,误分类高风险静脉曲张4.3%(3/70),灵敏度95.71%、特异度76.38%、阴性预测值98.57%、阴性似然比0.06。

关键数值与推荐

  • Baveno VI标准:使37.0%(126/341)患者免于食管胃十二指肠镜检查,未漏诊高风险静脉曲张(0/70)。
  • 脾硬度测量cut-off≤46.0 kPa:漏诊高风险静脉曲张4.3%。
  • 联合模型(Baveno VI标准且脾硬度≤46 kPa):覆盖61.6%(210/341)患者,漏诊高风险静脉曲张4.3%(3/70),灵敏度95.71%、特异度76.38%、阴性预测值98.57%、阴性似然比0.06。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: There are no data validating the performance of spleen stiffness measurement in ruling out high-risk varices in patients with HBV-related cirrhosis under maintained viral suppression. Thus, we aimed to prospectively validate the performance of spleen stiffness measurement (cut-off 46 kPa) combined with Baveno VI criteria in ruling out high-risk varices in these patients. METHODS: Patients with cirrhosis were enrolled from April to December 2019 at the hepatology unit of the Nanfang Hospital, China. Liver and spleen transient elastography and esophagogastroduodenoscopy were performed at enrollment. Antiviral regimen(s) and virological responses, evaluated every 3-6 months, were recorded. RESULTS: Overall 341 patients with HBV-related cirrhosis under maintained viral suppression were enrolled, and the prevalence of high-risk varices was 20.5% (70/341). Baveno VI criteria spared 37.0% (126/341) esophagogastroduodenoscopies and no high-risk varices were missed (0/70). Eight cases of high-risk varices (8/70, 11.4%) were misclassified in patients (208/341, 61.0%) within the expanded Baveno VI criteria. The spleen stiffness measurement cut-off (≤46.0 kPa) was shown to safely rule out high-risk varices in these patients (the percentage of missed high-risk varices was 4.3%). Over half (61.6%, 210/341) of patients met the combined model (Baveno VI criteria and spleen stiffness measurement cut-off ≤46 kPa) and 4.3% (3/70) of high-risk varices cases were misclassified. This combined model exhibited a sensitivity of 95.71%, specificity of 76.38%, negative predictive value of 98.57%, and negative likelihood ratio of 0.06 for ruling out high-risk varices. CONCLUSIONS: We validated the excellent performance of Baveno VI criteria combined with spleen stiffness measurement (cut-off 46 kPa) for safely ruling out high-risk varices in patients with HBV-related cirrhosis under viral suppression; more than half of esophagogastroduodenoscopy procedures were spared using this combination. CLINICAL TRIAL NUMBER: NCT04123509 LAY SUMMARY: Esophageal varices have important prognostic implications in patients with cirrhosis. Thus, their timely identification is important so that treatment can be initiated early. Herein, we validated the excellent performance of the combination of Baveno VI criteria with spleen stiffness measurement (cut-off 46 kPa) for ruling out high-risk esophageal varices in patients with HBV-related cirrhosis under maintained viral suppression (with antiviral treatment). This combined model was able to safely rule out high-risk varices (missed/total <5%) and over half (61.6%) of esophagogastroduodenoscopy procedures were spared.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Wang H, Wen B, Chang X, et al. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis. J Hepatol. 2020. PMID: 33039403. doi:10.1016/j.jhep.2020.09.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。